BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 33502939)

  • 1. Intratracheal administration of mesenchymal stem cell-derived extracellular vesicles reduces lung injuries in a chronic rat model of bronchopulmonary dysplasia.
    Porzionato A; Zaramella P; Dedja A; Guidolin D; Bonadies L; Macchi V; Pozzobon M; Jurga M; Perilongo G; De Caro R; Baraldi E; Muraca M
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L688-L704. PubMed ID: 33502939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratracheal administration of clinical-grade mesenchymal stem cell-derived extracellular vesicles reduces lung injury in a rat model of bronchopulmonary dysplasia.
    Porzionato A; Zaramella P; Dedja A; Guidolin D; Van Wemmel K; Macchi V; Jurga M; Perilongo G; De Caro R; Baraldi E; Muraca M
    Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L6-L19. PubMed ID: 30284924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Alleviate Lung Injury in Rat Model of Bronchopulmonary Dysplasia by Affecting Cell Survival and Angiogenesis.
    You J; Zhou O; Liu J; Zou W; Zhang L; Tian D; Dai J; Luo Z; Liu E; Fu Z; Zou L
    Stem Cells Dev; 2020 Dec; 29(23):1520-1532. PubMed ID: 33040709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension.
    Sharma M; Bellio MA; Benny M; Kulandavelu S; Chen P; Janjindamai C; Han C; Chang L; Sterling S; Williams K; Damianos A; Batlahally S; Kelly K; Aguilar-Caballero D; Zambrano R; Chen S; Huang J; Wu S; Hare JM; Schmidt A; Khan A; Young K
    Stem Cells Transl Med; 2022 Aug; 11(8):828-840. PubMed ID: 35758326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.
    Sammour I; Somashekar S; Huang J; Batlahally S; Breton M; Valasaki K; Khan A; Wu S; Young KC
    PLoS One; 2016; 11(10):e0164269. PubMed ID: 27711256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late Rescue Therapy with Cord-Derived Mesenchymal Stromal Cells for Established Lung Injury in Experimental Bronchopulmonary Dysplasia.
    O'Reilly M; Möbius MA; Vadivel A; Ionescu L; Fung M; Eaton F; Greer JJ; Thébaud B
    Stem Cells Dev; 2020 Mar; 29(6):364-371. PubMed ID: 31918630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicles From Mesenchymal Umbilical Cord Cells Exert Protection Against Oxidative Stress and Fibrosis in a Rat Model of Bronchopulmonary Dysplasia.
    Bisaccia P; Magarotto F; D'Agostino S; Dedja A; Barbon S; Guidolin D; Liboni C; Angioni R; De Lazzari G; Caicci F; Viola A; Jurga M; Kundrotas G; Stevens D; Mancuso D; Gramegna E; Seitaj B; Kashyap R; De Vos B; Macchi V; Baraldi E; Porzionato A; De Caro R; Muraca M; Pozzobon M
    Stem Cells Transl Med; 2024 Jan; 13(1):43-59. PubMed ID: 37963808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor mediates the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles against neonatal hyperoxic lung injury.
    Ahn SY; Park WS; Kim YE; Sung DK; Sung SI; Ahn JY; Chang YS
    Exp Mol Med; 2018 Apr; 50(4):1-12. PubMed ID: 29650962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cell-Derived Extracellular Vesicles Suppress Hyperoxia-Induced Transdifferentiation of Rat Alveolar Type 2 Epithelial Cells.
    Ai D; Shen J; Sun J; Zhu Z; Gao R; Du Y; Yuan L; Chen C; Zhou J
    Stem Cells Dev; 2022 Feb; 31(3-4):53-66. PubMed ID: 34913742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratracheal transplantation of mesenchymal stem cells simultaneously attenuates both lung and brain injuries in hyperoxic newborn rats.
    Kim YE; Park WS; Sung DK; Ahn SY; Sung SI; Yoo HS; Chang YS
    Pediatr Res; 2016 Sep; 80(3):415-24. PubMed ID: 27064241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stromal Cell Exosomes Ameliorate Experimental Bronchopulmonary Dysplasia and Restore Lung Function through Macrophage Immunomodulation.
    Willis GR; Fernandez-Gonzalez A; Anastas J; Vitali SH; Liu X; Ericsson M; Kwong A; Mitsialis SA; Kourembanas S
    Am J Respir Crit Care Med; 2018 Jan; 197(1):104-116. PubMed ID: 28853608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effects of Bone Marrow-derived Versus Umbilical Cord Tissue Mesenchymal Stem Cells in an Experimental Model of Bronchopulmonary Dysplasia.
    Benny M; Courchia B; Shrager S; Sharma M; Chen P; Duara J; Valasaki K; Bellio MA; Damianos A; Huang J; Zambrano R; Schmidt A; Wu S; Velazquez OC; Hare JM; Khan A; Young KC
    Stem Cells Transl Med; 2022 Mar; 11(2):189-199. PubMed ID: 35298658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell treatment in hyperoxia-induced lung injury in newborn rats.
    Gülaşı S; Atıcı A; Yılmaz ŞN; Polat A; Yılmaz M; Laçin MT; Örekici G; Çelik Y
    Pediatr Int; 2016 Mar; 58(3):206-213. PubMed ID: 26208034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma.
    Potter DR; Miyazawa BY; Gibb SL; Deng X; Togaratti PP; Croze RH; Srivastava AK; Trivedi A; Matthay M; Holcomb JB; Schreiber MA; Pati S
    J Trauma Acute Care Surg; 2018 Feb; 84(2):245-256. PubMed ID: 29251710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic effect of mesenchymal stem cells on pulmonary myeloid cells following neonatal hyperoxic lung injury in mice.
    Al-Rubaie A; Wise AF; Sozo F; De Matteo R; Samuel CS; Harding R; Ricardo SD
    Respir Res; 2018 Jun; 19(1):114. PubMed ID: 29884181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose Stem Cells Derived Exosomes Alleviate Bronchopulmonary Dysplasia and Regulate Autophagy in Neonatal Rats.
    Sun Y; Chen C; Liu Y; Sheng A; Wang S; Zhang X; Wang D; Wang Q; Lu C; Lin Z
    Curr Stem Cell Res Ther; 2024; 19(6):919-932. PubMed ID: 37817518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells from different sources show distinct therapeutic effects in hyperoxia-induced bronchopulmonary dysplasia in rats.
    Xie Y; Chen F; Jia L; Chen R; Zhang VW; Zhong X; Wang D
    J Cell Mol Med; 2021 Sep; 25(17):8558-8566. PubMed ID: 34322990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell type-dependent variation in paracrine potency determines therapeutic efficacy against neonatal hyperoxic lung injury.
    Ahn SY; Chang YS; Sung DK; Yoo HS; Sung SI; Choi SJ; Park WS
    Cytotherapy; 2015 Aug; 17(8):1025-35. PubMed ID: 25863963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia.
    Reiter J; Drummond S; Sammour I; Huang J; Florea V; Dornas P; Hare JM; Rodrigues CO; Young KC
    Respir Res; 2017 Jul; 18(1):137. PubMed ID: 28701189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stem Cells and Formyl Peptide Receptor 2 Activity in Hyperoxia-Induced Lung Injury in Newborn Mice.
    Kim YE; Ahn SY; Sung DK; Chang YS; Park WS
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.